Agonist News and Research

RSS

HKBU researchers develop metal based probes for imaging dopamine receptors in living cells

A team led by Dr Edmond Ma Dik-lung, Associate Professor of the Department of Chemistry of Hong Kong Baptist University has developed the world's first iridium(III)-based probes for imaging dopamine receptors in living cells.

16 May 2018

Study explains anti-obesity effects of melatonin

A new study has revealed the mechanism behind the anti-obesity effects of melatonin, a hormone that is released by the pineal gland in the brain overnight.

11 May 2018

Researchers find novel approach for in vivo real-time monitoring of metabolites

Real-time monitoring of the dynamics of endogenous molecules in organisms is an important aspect in the study of diseases.

2 May 2018

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances.

28 Apr 2018

Wide-scale distribution of naloxone effectively prevents overdose deaths, study finds

A new study in The Lancet Public Health shows the rapid expansion of British Columbia's Take Home Naloxone program significantly reduced the number of fentanyl-related overdose deaths in 2016.

18 Apr 2018

Study compares survival outcomes of different drugs for type 2 diabetes

In a comparison of different classes of drugs used to lower blood sugar levels for patients with type 2 diabetes, sodium-glucose cotransporter 2 (SGLT-2) inhibitors or glucagon-like peptide 1(GLP-1) agonists were associated with a lower risk of death than dipeptidyl peptidase 4 (DPP-4) inhibitors or control (placebo or no treatment).

17 Apr 2018

One class of diabetes drug not associated with reduced risk of death

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

17 Apr 2018

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

13 Apr 2018

New review explores potentially safer therapies for treating chronic abdominal pain

An estimated 2 million people in the U.S. are addicted to prescription opioids- powerful doctor-prescribed medications for chronic or severe pain. The drugs are commonly prescribed to treat gastrointestinal pain caused by conditions such as Crohn's disease and irritable bowel syndrome (IBS), raising the risk of addiction among this population.

29 Mar 2018

SLU researchers turn off excruciating chemo pain in animal model

In a recent paper published in the journal Pain, Saint Louis University researchers describe their success in an animal model in turning off the excruciating pain that often accompanies a colorectal cancer drug.

26 Mar 2018

New diabetes drug may help obese people shed body weight

A compound that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight, a new study suggests.

19 Mar 2018

Scientists develop novel assay for studying molecular determinants of bronchoconstriction/dilation

Contraction and relaxation of smooth muscle cells and fibroblasts within the bronchial airways dramatically affects airflow, and being able to modulate these processes is critical for treating asthma and allergic responses.

13 Mar 2018

ACEA Biosciences develops novel assay for rapid identification of endocrine-disrupting chemicals

Endocrine-disrupting chemicals are substances that interfere with the ability of endogenous hormones to regulate homeostasis via their cognate nuclear receptors.

13 Mar 2018

Two types of blood pressure medications linked to increased variability, higher risk of death

Two types of blood pressure medications - alpha blockers and alpha 2 agonist - show increased variability in blood pressure measurements between doctor visits, which is associated with an increased risk of death, according to new research from the Intermountain Medical Center Heart Institute in Salt Lake City.

13 Mar 2018

Agonist News and Research

HKBU researchers develop metal based probes for imaging dopamine receptors in living cells

Study explains anti-obesity effects of melatonin

Researchers find novel approach for in vivo real-time monitoring of metabolites

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Wide-scale distribution of naloxone effectively prevents overdose deaths, study finds

Study compares survival outcomes of different drugs for type 2 diabetes

One class of diabetes drug not associated with reduced risk of death

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

New review explores potentially safer therapies for treating chronic abdominal pain

SLU researchers turn off excruciating chemo pain in animal model

New diabetes drug may help obese people shed body weight

Scientists develop novel assay for studying molecular determinants of bronchoconstriction/dilation

ACEA Biosciences develops novel assay for rapid identification of endocrine-disrupting chemicals

Two types of blood pressure medications linked to increased variability, higher risk of death

Researchers identify new mechanism to disrupt HIV latency

Slow-release injectable gel boosts toxicity of cancer-fighting immunotherapy drugs

New suggests different approach to eczema treatment

New Canadian guideline lays out optimal strategies for treatment of opioid addiction

Gastric bypass can provide better outcomes for patients with obesity and diabetes than lifestyle intervention

Study finds novel therapeutic strategy that preserves neuromuscular synapses in ALS mouse model

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News